Search
-
OfferLab Technician
-
CompanyOneChain Immunotherapeutics
-
Press release
We’ve been awarded a one million euro grant by the Ministry of Science to study brain tumo...
The Spanish government has announced the public grants corresponding to the State Program for research, development and innovation call — geared towards societal challenges and called “Collaboration
-
Press release
ORYZON to present further positive efficacy data from iadademstat ALICE Phase IIa trial at...
Will also present at Jefferies 2020 Virtual London Healthcare Conference. CEO to participate in a Borderline Personality Disorder Day panel
-
-
-
-
Press release
ORYZON receives approval to start PORTICO Phase IIb trial with vafidemstat in Borderline P...
Clinical Trial Application approved by Spanish Drug Agency
-
EventSpringer Nature panel discussion: AI, Ethics, and your Business
Springer’s new journal, AI and Ethics seeks to promote informed debate and discussion of the ethical, regulatory, and policy implications that arise from the development of AI
-
EventUK-Spain Covid-19 Vaccines Roundtable
The British Embassy in Madrid and the Consulate General in Barcelona organize this bilateral session, which will bring together key players to discuss current and future
-
Offer
Postdoctoral Position
-
EventStart at the End: What to Show the Regulators?
Johnson & Johnson Innovation – JLABS brings you a program with learnings that may help you smooth your regulatory approach.
-
EventColorize the Blueprint for your Biologics Clinical Trial Application
Johnson & Johnson Innovation – JLABS invites you to an in-depth look into CMC strategies and clinical trial design
-
EventGlobal Innovation 2021 Ayming barometer: COVID-19 and beyond
Discover some exclusive insights from Ayming’s second edition of the International Innovation Barometer during our webinar, takin place on 12th November 2020.
-
Press release
Oryzon announces appointment of Dr. Torsten Hoffmann as Global R&D Director and retirement...
At Roche, Dr. Hoffmann was Head of Discovery Chemistry and Head of the Roche Postdoc Fellowship Program. Subsequently he served as Chief Scientific Officer and Executive VP at Zealand Pharma, Chief